Skip to content

Evidence-based Research on Risk Factor Analysis of Preoperative Pulmonary Embolism and Scientific Anticoagulant Therapy Regimens in Patients with Renal tumors and Inferior Vena Cava Tumor Thrombus

Evidence-based Research on Risk Factor Analysis of Preoperative Pulmonary Embolism and Scientific Anticoagulant Therapy Regimens in Patients with Renal tumors and Inferior Vena Cava Tumor Thrombus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093004
Enrollment
Unknown
Registered
2024-11-27
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma complicated with Inferior Vena Cava Tumor Thrombus

Interventions

Case series:None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with renal cell carcinoma with inferior vena cava tumor thrombus (RCC-IVCTT) who visited our center from 2006 to 2023. 2. Patients older than 18 years of age.

Exclusion criteria

Exclusion criteria: 1. Patients who have been receiving long-term anticoagulant therapy due to cardiovascular or other reasons. 2. Patients with bilateral renal tumors. 3. Patients with concurrent malignant tumors in other systems. 4. Patients with incomplete baseline data.

Design outcomes

Primary

MeasureTime frame
The incidence of preoperative pulmonary embolism (PE) in patients;Preoperative anticoagulation regimen;

Secondary

MeasureTime frame
Sex;Age;Baseline heart rate;BMI;Mayo classification;tumor size;IVC blocking rate;RENAL score;tumor side;Tumor pathological type;Comorbidity;SCR;BUN;ALT;AST;D-dimer;Thrombin;surgery method;operative time;Intraoperative blood loss;Perioperative active bleeding events;Whether the patient has undergone a second surgery or not.;Whether there was intraoperative hemodynamic instability.;

Countries

China

Contacts

Public ContactXin Ma

Department of Urology, Chinese PLA General Hospital

gdhuangqingbo@163.com+86 166 2935 1458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026